1. NOx and ADMA changes with focal ischemia, amelioration with the chaperonin GroEL.
- Author
-
Xu L, Wang B, Kaur K, Kho MF, Cooke JP, and Giffard RG
- Subjects
- Animals, Arginine blood, Arginine cerebrospinal fluid, Biomarkers analysis, Biomarkers blood, Biomarkers cerebrospinal fluid, Brain physiopathology, Brain Ischemia physiopathology, Cerebrovascular Circulation drug effects, Chaperonin 60 genetics, Cytoprotection genetics, Genetic Therapy methods, Infarction, Middle Cerebral Artery drug therapy, Infarction, Middle Cerebral Artery metabolism, Infarction, Middle Cerebral Artery physiopathology, Male, Nitric Oxide cerebrospinal fluid, Rats, Rats, Sprague-Dawley, Transfection methods, Up-Regulation physiology, Arginine analogs & derivatives, Brain drug effects, Brain metabolism, Brain Ischemia drug therapy, Brain Ischemia metabolism, Cerebrovascular Circulation physiology, Chaperonin 60 metabolism, Nitric Oxide blood
- Abstract
Both nitric oxide and asymmetric dimethylarginine (ADMA) play a critical role in the regulation of cerebral blood flow, though their neuroprotective and cytotoxic effects are still under investigation. In this study, we found that nitrate/nitrite (NOx) levels in plasma, ischemic brain tissue, and cerebrospinal fluid (CSF) increased significantly 24h after 2h transient middle cerebral artery occlusion (MCAO) in rats. ADMA levels were unchanged in plasma, but decreased significantly in CSF 24h following MCAO. The CSF ADMA/NOx ratio decreased markedly following ischemia. Rats protected by expression of the chaperonin GroEL or its folding deficient mutant D87K had lower plasma NOx levels at 24h reperfusion. ADMA, NO, and their ratio in CSF merit further study as biomarkers for ischemic brain injury.
- Published
- 2007
- Full Text
- View/download PDF